Trials / Completed
CompletedNCT05304845
Drug-drug Interactions Between DWP14012 and Aspirin in Healthy Subjects
A Randomized, Open-label Study to Evaluate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of Drug-drug Interactions Between DWP14012 and Aspirin in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- All
- Age
- 19 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
This is a randomized, open-label study to evaluate the safety/tolerability and PK/PD drug-drug interactions between DWP14012 and aspirin when administered in combination.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DWP14012 | Potassium-competitive acid blocker |
| DRUG | Aspirin | acetylsalicylic acid |
Timeline
- Start date
- 2022-03-21
- Primary completion
- 2022-05-22
- Completion
- 2022-05-22
- First posted
- 2022-03-31
- Last updated
- 2023-04-05
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05304845. Inclusion in this directory is not an endorsement.